Rx (Prescription Medicine)
USD $ 49.00
Lenvatol 4mg Capsule 是一种靶向治疗药物，用于治疗某些类型的癌症。其活性成分是 Lenvatinib，一种多靶点受体酪氨酸激酶抑制剂。Lenvatinib 通过阻断参与肿瘤生长、血管形成（血管生成）以及癌症进展的特定蛋白的活性发挥作用。通过抑制这些通路，Lenvatinib 有助于减慢或停止癌细胞的生长，并可缩小肿瘤体积。
Lenvatol 4mg Capsule 主要适应用于治疗不可手术切除的肝细胞癌（HCC），一种肝癌，以及对放射性碘治疗不应答的分化甲状腺癌。典型剂量为 4mg 每日口服一次，但具体剂量可根据癌症类型和患者反应而变化。必须严格按照医疗提供者的处方服用 Lenvatol。常见不良反应可能包括疲劳、腹泻、食欲下降、体重减轻、血压升高以及蛋白尿。严重不良反应可能发生，因此出现任何新出现或加重的症状应立即向医生报告。请将 Lenvatol 4mg Capsules 存放于室温，避免潮湿和热量，并放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Strength |
其他品牌的 Lenvatinib 4 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
